Immediate Impact

9 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
2024 Standout
1 intermediate paper

Works of Wegene Borena being referenced

Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults
2011
Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study
2010

Author Peers

Author Last Decade Papers Cites
Wegene Borena 292 404 276 445 351 60 1.3k
Ariel Hammerman 335 198 91 92 173 63 1.1k
Zhiping Qian 538 223 234 94 197 37 1.3k
Charles E. Hill 210 172 142 86 286 80 1.4k
Yan Xiong 723 161 113 94 267 73 1.5k
Guangtong Deng 496 181 133 328 537 64 1.5k
Furong Zeng 502 169 143 375 600 66 1.6k
Ziying Lei 484 150 151 325 409 39 1.2k
Bingliang Lin 311 376 410 118 335 51 1.3k
Aaron J. Scott 52 175 182 140 267 85 1.1k
Juan Manuel Mejía‐Aranguré 147 458 80 123 205 100 1.4k

All Works

Loading papers...

Rankless by CCL
2026